SPPI - Analysis on New 78 Day High

How SPPI had turned to become a massive winner in just 2 months time?
The Pattern:

1. A breakout from 200SMA
2. New high (h1) is created with New Low(L1) all above 200SMA
3. Another New high (h2) breaks out of h1 with New 55 day High (N55).
4. h2/L2/L3 above 200SMA. The lows are ascending above 200SMA.
5. A new high is again created (h3) breaking out of h2. This 2nd New high breakout associated with a Gap and Volume almost 200% than previous volume of the past 8 to 10 weeks.
6. Entry: 3/4 of h3
7. Exit: 3rd N78

WHAT TO LOOK FOR IN A CHART:

1 Year Chart

6 mon Chart

3 mon Chart

New 78 Day High following a Rickshaw candle - AYX

AYX was a real winner after a New 78 Day High following a rickshaw candle formation last Aug. 3, 2017. After the New 78 Day High it pulled back to the ema(200) line exactly the same height as the tail of the rickshaw below the low of that rickshaw candle of Aug. 3, 2017. From there it consolidated and made another breakout after 3 months time and never looked back. From the high of $23.00 it went up to $83.00

Accelotrade

Accelotrade

Trading with AI
Trading Practice
Trading Peek

New Nano Degree Programs at Udacity:

1. Robotics Software Engineer - School of Autonomous System
2. Google Analytics - School of Business
3. Artificial Intelligence for Trading - School of Autonomous System

Game Programming 

1. Unity 3D (From Udemy, Become a game deve;oper,  from Unity 3D

RFIL - New 55 Days High with 200%+ Volume

Jan 15, 2019

Below is a study of how to play stocks that reached New 55 Days High.

RFIL - RF INDUSTRIES, Inc. 
Last Jan. 24, 2018 jumped from 2.60 to 3.48 hitting New 55 Days High with volume surpassing the 200% level. If you notice the Breakout occurred in the following successions.

1. The Price broke out above SMA(200) last May 26, 2017 which failed but 18 days later broke out again above that SMA(200) and followed with a breakout of SMA(30) and SMA(50) above SMA(200). See Fig. 1
2. H1 Breakout. This is a breakout of the previous high after breaking the 200SMA.
3. H2 Breakout. The New high of No.2 was broken on the upside with 
4. New 55 Days High and a volume above 200% level.
5. LH going higher. The Lower Highs are trending higher just touching the SMA(30) but never below the low of the Jan. 24, 2018 breakout candle. Your ENTRY could be the second touch on the SMA(30).
6. Dividend was announced on March 9, 2018. This was a very strong catalyst, although the chart showed a red bearish candle breaking down the SMA(30) with 41K of volume a little above the average 30K volume. Ordinary investors may get scared on this chart outlook, but this is what the Market maker and Hedge Fund Mangers are looking for so they can position cheaply with the stock. See Fig. 2
7. Another Catalyst on March 13, 2018 happened. A news broke out that its sales jumped by 55%. RFIL gapped-up with a huge jump from 3.50 to a high of 5.48 a day after when that news was released. This gap is associated with another New 55 Days High. Here you could have added your position right at the neckline of the Gap up candle. That would be additional position. See Fig. 3
8. Exit on R2 high. R2 is the measure equivalent to R1. R1 is taken from the previous high before it gapped up on June 11, 2018. It is measured from previous day's high to the high of the gap-up.

Had you entered at $3.00 and exited at $12.00 you could have made 400% of your trade.

FIG. 1 RFIL breaking out of SMA(200) + New 55 Days High

FIG. 2 RFIL with the Catalyst (Dividend Announcement + High Sales)

FIG. 3 Another New 55 days High after Dividend and High sales News.

FIG. 4 RFIL making 400% gain from $3.00 to $12.00

Study this strategy for this is a very potent and rewarding strategy.

NEO hitting MINOLA on stockfetcher

NEO. NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States. It operates through Clinical Services and Pharma Services segments. The company laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. The company has a strategic alliance with Pharmaceutical Product Development Inc. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

NOTE: NEO like LXFR and NTWK came out of the MINOLA filter I have in stockfetcher.

TECHNICAL:
4 Days Breakout on previous high of $15.50 reaching a high of $19.00. Possible pullback at $17.00.

NEWS AND CATALYST:
The following are excerpts from yahoo finance.

October 30, 2018, NEO reported 17% growth in revenue ($69M).

Third Quarter 2018 Highlights:

•   17% increase in consolidated revenue  

•   14% increase in clinical genetic testing volume(1)

•   21% increase in Pharma Services revenue; 75% increase in Pharma Services backlog

•   Completed $135 million, net equity offering 

•   Announced acquisition of Genoptix in October for $125 million in cash and 1 million shares of NeoGenomics common stock

CHART (1 Year)

 CHART (2 Years)

FINVIZ
Finviz has a target of $20.71. Based on its EPS Q/Q of 342% it has a very strong fundamental. Sales Q/Q  is not that big which is 8.70%. But with the current news of having beaten estimates with its Q3 Earnings and Revenue, there is a big chance this stock can still soar high.

BIG CHARTS (NEO in 1 Decade vs NASDAQ). 

NEO had a huge divergence against NASDAQ. 

 BIG CHARTS (NEO in 1 Decade)

STOCKCHARTS.COM (NEO, LXFR, NTWK vs NASDAQ in 3 Years Chart)

As you can see in the comparison against NASDAQ, NEO had gained 187% compared to NASDAQ of 46.64%

STOCKCHARTS.COM (NEO vs NASDAQ in 3 months Chart)

This chart is meant to show the divergence created by NEO against the NASDAQ composite. While NASDAQ broke down on the last week of October 2018, NEO went breaking out of previous high and created new highs.

To see how to enter in this kind of stock, please go to https://excel4stocks.blogspot.com/2019/03/neo-hitting-minola-and-how-to-position.html

LXFR hitting MINOLA on stockfetcher

LXFR
Luxfer is a materials technology company, that designs, manufactures, and supplies high-performance materials, components, and high-pressure gas-containment devices for transportation, defense and emergency response, healthcare, and general industrial applications in Europe, North America, the Asia Pacific, and internationally.

It has two operations. The Gas Cylinders and Elektron.

The Gas Cylinders manufactures and markets aluminum and composite cylinders and systems, which are used in self-contained breathing apparatus, fire extinguishers, alternative fuels, bulk gas transportation, specialty gases, medical, beverages, scuba, and aerospace applications under the Luxfer Gas Cylinders brand. This operation also designs and manufactures aluminum, titanium, and magnesium plates for use in aerospace, automotive, rail, and medical products under the Superform brand.

The Elektron focuses on specialty materials based on magnesium, zirconium, and rare earths. It develops and manufactures magnesium alloys; magnesium powders; and magnesium, copper, and zinc photoengraving plates. This operation also develops and manufactures specialty zirconium products, including zirconium-based materials, zirconium oxides, fiber-optic fuel cells, and other products. The company was founded in 1898 and is based in Manchester, the United Kingdom.

NOTE:
MINOLA is the acronym of Minervini, O'Neil and Larry Williams. This a filter I created that combines the 3 strategies of these 3 wizzards of Stock Market. The filter tries to capture the Minervini SEPA strategy, the O'Neil Pocket Pivot and the ADX(14) of larry Williams. I created this filter in stockfetcher.com

TECHNICAL:
Nov. 06, 2018 flagged as MINOLA on my stockfetcher with a significant volume of 535K breaking out the Aug. 23, 2018 volume of 374K and leveled the previous volume last April 26, 2017. Based on the previous breakout last may 10, 2018 it rose from $15 to $17 and pulled back somewhere at $16.00. With this new breakout the rise is around $23.00 to $28.00. Give or take the pull back could be somewhere around $25.00 or $24.00.

NEWS: Zack bet on this stock as one one with Good Net Margin

CHART (2 Years)

CHART (1 Year)

FINVIZ:

LXFR has a very high EPS Quarter per Quarter (EPS Q/Q) which is 296% and the Sales Quarter per Quater (Sales Q/Q) is also on the positive side which is 20.30%. The target that Finviz set is $15.00 which is very low. But it could also be possible since the stock had gone very far from the 200SMA (the green line on the above chart.)

In case this stock falls to $15.00, take a look at the following chart of NMIH. A similar configuration might happen.

BIG CHART (LXFR on 1 decade against NASDAQ):
Looking at the Decade chart of LXFR on Bigcharts.com the stock had actually broken out previous high and had created a divergence against the NASDAQ chart. This divergence could mean a year of new high just like in 2013.

BIG CHART (LXFR on 1 Decade)

BIG CHART (LXFR on 1 Year)

VERU analysis using VCP of Mark Minervini

Last March 20, 2018 I posted an article "The Power of Women", about how women are sharing the responsibility and power of birth control using condom. But instead of men using the condom, it's the women using it. At that time the price reached $2.16 with Finviz sharing their target at $5.00. Previous to that time around March 5, 2018, VERU had completed Royalty Financing  on their FC2 business (the condom business) to avoid dilution of funds. Its stock price closed at $1.43. Today the stock stands at around $2.25, slightly higher than the resistance of $2.2 which had been the triple top resistance line. Creating a VCP (Volatility Contraction Pattern) lines which connects the Lower Highs (LH) and the Higher Lows (HL) forming a triangular flag. As we can see there had been three flag patterns that appeared in increasing size making a triple Fan formation. A breakout on this 3rd fan with price reaching $2.4 and pulling back at $2.2 support line would be a start of a new strong upside potential.

Applying the VCP (Volatility Contraction Pattern) of Mark Minervini he illustrated in his book "Trade Like a Market Wizzard", we can see that the current reading is  22P-3T-122d (22% contraction from its previous high (June 13, 2018) to latest low (Jul 31, 2018). From Sep 27, 2017 up until the latest low (Jul 31, 2018) the latest low is the 3rd Touch of the VCP bottom line. And it had been 122 days since that high of $3.00.

We need to stay close attention of this contraction when it comes around 6% to 5%. For now, it is a waiting game for the sniper on this Stock.

So far the stock had New 55 days High (N55) with volume more than 200% (VP) than the usual volume twice but was hammered when reaching $2.25. If it breaks out and make New 78 days high, then this will be soaring upward.

3 Things we are looking for:

1. VCP percentage contraction of around 6% or 5%.
2. Breakout on the 3rd Fan VCP with a breakout of the  $2.25 resistance
3. High Volume of more than 200% and a New 78 day High.